Correspondence 0001437749-24-009808 from BioCardia, Inc. (BCDA)
BioCardia, Inc.
Date: March 28, 2024 · CIK: 0000925741 · Accession: 0001437749-24-009808
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-277059
Letter
bcda20240328_corresp.htm
BioCardia, Inc.
320 Soquel Way
Sunnyvale, California 94085
March 28, 2024
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Washington, D.C. 20549-3561
Re: BioCardia, Inc.
Registration Statement on Form S-3
Filed February 14, 2024
File No. 333-277059
Acceleration Request
Requested Date: April 1, 2024
Requested Time: 4:30 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-277059) (the “Registration Statement”), be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Company may request by telephone to the staff of the Securities and Exchange Commission.
The Company hereby authorizes Austin March of Wilson Sonsini Goodrich & Rosati, P.C., counsel for the Company, to make such request on the Company’s behalf.
The Company requests that it be notified of the effectiveness of the Registration Statement by contacting Austin March at (512) 338-5410 or amarch@wsgr.com.
Sincerely,
BIOCARDIA, INC.
Show Raw Text
CORRESP 1 filename1.htm bcda20240328_corresp.htm BioCardia, Inc. 320 Soquel Way Sunnyvale, California 94085 March 28, 2024 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549-3561 Re: BioCardia, Inc. Registration Statement on Form S-3 Filed February 14, 2024 File No. 333-277059 Acceleration Request Requested Date: April 1, 2024 Requested Time: 4:30 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-277059) (the “Registration Statement”), be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Company may request by telephone to the staff of the Securities and Exchange Commission. The Company hereby authorizes Austin March of Wilson Sonsini Goodrich & Rosati, P.C., counsel for the Company, to make such request on the Company’s behalf. The Company requests that it be notified of the effectiveness of the Registration Statement by contacting Austin March at (512) 338-5410 or amarch@wsgr.com. Sincerely, BIOCARDIA, INC. By: /s/ David McClung David McClung Chief Financial Officer cc: Peter Altman, BioCardia, Inc. Austin March, Esq., Wilson Sonsini Goodrich & Rosati, P.C.